EUVIMEDEUVIMED entdecken
Crossref

RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells

Wan-Ling Liao, Ho Lin iD, Yu-Hsuan Li, Tsung-Ying Yang, Mei-Chih Chen iD

American Journal of Physiology-Cell Physiology · 2023

DOI: 10.1152/ajpcell.00494.2022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2023. Verfasst von Wan-Ling Liao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study represents a pioneering endeavor in comprehending the intricate interplay between RAGE and EGFR signaling within NSCLC. The findings reveal that RAGE serves to enhance EGFR phosphorylation and activation, consequently modulating apoptosis regulators through the EGFR-STAT3 and EGFR-Erk1/2 signaling pathways. Through this mechanism, RAGE potentially imparts resistance to the toxicity induced by EGFR-TKIs in NSCLC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansGefitinibReceptor for Advanced Glycation End ProductsLigandsQuinazolinesDrug Resistance, NeoplasmCell Line, TumorErbB ReceptorsExtracellular Signal-Regulated MAP KinasesProto-Oncogene Proteins c-bcl-2Carcinogenesis

Stichwörter der Autor:innen

EGFRNSCLCRAGESTAT3gefitinib

Substanzen

GefitinibReceptor for Advanced Glycation End ProductsLigandsQuinazolinesErbB ReceptorsExtracellular Signal-Regulated MAP KinasesProto-Oncogene Proteins c-bcl-2EGFR protein, human

Autor:innen und Institutionen

  • Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan.
  • Department of Medical Research, Translational Cell Therapy Center, China Medical University Hospital, Taichung, Taiwan.
  • Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.

ORCID-Profile: Ho Lin, Mei-Chih Chen

Förderung

  • Ministry of Science and Technology, Taiwan

Zitieren

APA

Liao, W. L., Lin, H., Li, Y. H., Yang, T. Y., & Chen, M. C. (2023). RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00494.2022

Vancouver

Liao WL, Lin H, Li YH, Yang TY, Chen MC. RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells. American Journal of Physiology-Cell Physiology. 2023. doi:10.1152/ajpcell.00494.2022

BibTeX
@article{Liao2023,
  author = {Liao, Wan-Ling and Lin, Ho and Li, Yu-Hsuan and Yang, Tsung-Ying and Chen, Mei-Chih},
  title = {RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2023},
  doi = {10.1152/ajpcell.00494.2022}
}
Kostenlos starten →